BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18600530)

  • 1. RNAi depletion of deoxycytidine and deoxyguanosine kinase in human leukemic CEM cells.
    Fyrberg A; Albertioni F; Lotfi K
    Nucleosides Nucleotides Nucleic Acids; 2008 Jun; 27(6):712-9. PubMed ID: 18600530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arabinosylguanine is phosphorylated by both cytoplasmic deoxycytidine kinase and mitochondrial deoxyguanosine kinase.
    Rodriguez CO; Mitchell BS; Ayres M; Eriksson S; Gandhi V
    Cancer Res; 2002 Jun; 62(11):3100-5. PubMed ID: 12036920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nucleoside Analog Activity in Malignant Melanoma Cell Lines.
    Fyrberg A; Lotfi K
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(9):639-49. PubMed ID: 26252632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pattern of deoxycytidine- and deoxyguanosine kinase activity in relation to messenger RNA expression in blood cells from untreated patients with B-cell chronic lymphocytic leukemia.
    Lotfi K; Karlsson K; Fyrberg A; Juliusson G; Jonsson V; Peterson C; Eriksson S; Albertioni F
    Biochem Pharmacol; 2006 Mar; 71(6):882-90. PubMed ID: 16436271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-time quantitative PCR assays for deoxycytidine kinase, deoxyguanosine kinase and 5'-nucleotidase mRNA measurement in cell lines and in patients with leukemia.
    Månsson E; Liliemark E; Söderhäll S; Gustafsson G; Eriksson S; Albertioni F
    Leukemia; 2002 Mar; 16(3):386-92. PubMed ID: 11896543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Depletion of mitochondrial DNA by down-regulation of deoxyguanosine kinase expression in non-proliferating HeLa cells.
    Franco M; Johansson M; Karlsson A
    Exp Cell Res; 2007 Jul; 313(12):2687-94. PubMed ID: 17490647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphorylation of anticancer nucleoside analogs by human mitochondrial deoxyguanosine kinase.
    Zhu C; Johansson M; Permert J; Karlsson A
    Biochem Pharmacol; 1998 Oct; 56(8):1035-40. PubMed ID: 9776315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle effect on the activity of deoxynucleoside analogue metabolising enzymes.
    Fyrberg A; Albertioni F; Lotfi K
    Biochem Biophys Res Commun; 2007 Jun; 357(4):847-53. PubMed ID: 17459340
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Docking simulation with a purine nucleoside specific homology model of deoxycytidine kinase, a target enzyme for anticancer and antiviral therapy.
    Johnsamuel J; Eriksson S; Oliveira M; Tjarks W
    Bioorg Med Chem; 2005 Jul; 13(13):4160-7. PubMed ID: 15876539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
    Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
    Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acute cytotoxicity of arabinofuranosyl nucleoside analogs is not dependent on mitochondrial DNA.
    Curbo S; Johansson M; Balzarini J; Lewis LD; Karlsson A
    Exp Cell Res; 2009 Sep; 315(15):2539-43. PubMed ID: 19481540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low level of mitochondrial deoxyguanosine kinase is the dominant factor in acquired resistance to 9-beta-D-arabinofuranosylguanine cytotoxicity.
    Lotfi K; Månsson E; Peterson C; Eriksson S; Albertioni F
    Biochem Biophys Res Commun; 2002 May; 293(5):1489-96. PubMed ID: 12054684
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of deoxycytidine kinase in human leukemic cell lines resistant to cladribine and clofarabine and increased ribonucleotide reductase activity contributes to fludarabine resistance.
    Månsson E; Flordal E; Liliemark J; Spasokoukotskaja T; Elford H; Lagercrantz S; Eriksson S; Albertioni F
    Biochem Pharmacol; 2003 Jan; 65(2):237-47. PubMed ID: 12504799
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytosine arabinoside affects multiple cellular factors and induces drug resistance in human lymphoid cells.
    Sarkar M; Han T; Damaraju V; Carpenter P; Cass CE; Agarwal RP
    Biochem Pharmacol; 2005 Aug; 70(3):426-32. PubMed ID: 15950950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential of ribozymes against deoxycytidine kinase to confer drug resistance to cytosine nucleoside analogs.
    Beauséjour CM; Tremblay G; Momparler RL
    Biochem Biophys Res Commun; 2000 Nov; 278(3):569-75. PubMed ID: 11095951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Casein kinase 1delta activates human recombinant deoxycytidine kinase by Ser-74 phosphorylation, but is not involved in the in vivo regulation of its activity.
    Smal C; Vertommen D; Amsailale R; Arts A; Degand H; Morsomme P; Rider MH; Neste EV; Bontemps F
    Arch Biochem Biophys; 2010 Oct; 502(1):44-52. PubMed ID: 20637175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retroviral transfer of deoxycytidine kinase into tumor cell lines enhances nucleoside toxicity.
    Hapke DM; Stegmann AP; Mitchell BS
    Cancer Res; 1996 May; 56(10):2343-7. PubMed ID: 8625309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of deoxycytidine kinase by protein kinase inhibitors and okadaic acid in leukemic cells.
    Smal C; Cardoen S; Bertrand L; Delacauw A; Ferrant A; Van den Berghe G; Van Den Neste E; Bontemps F
    Biochem Pharmacol; 2004 Jul; 68(1):95-103. PubMed ID: 15183121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of deoxynucleoside kinases and 5'-nucleotidases in mouse tissues: implications for mitochondrial toxicity.
    Rylova SN; Mirzaee S; Albertioni F; Eriksson S
    Biochem Pharmacol; 2007 Jun; 74(1):169-75. PubMed ID: 17493587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of normal and malignant cells with nucleoside analogues and etoposide enhances deoxycytidine kinase activity.
    Spasokoukotskaja T; Sasvári-Székely M; Keszler G; Albertioni F; Eriksson S; Staub M
    Eur J Cancer; 1999 Dec; 35(13):1862-7. PubMed ID: 10674004
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.